SCHEMBL18656955

SCHEMBL18656955

O=C1CC(=O)N(CC(F)c2cccc(F)c2)C(=O)N1CCc1cccc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ USP2 O75604 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ SLC6A3 Q01959 2/20 0.42
▸ DAO P14920 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ BLM P54132 2/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10159299 0.89 OPRM1 (0.40) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL10159225 0.89 OPRM1 (0.40) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL10159267 0.89 OPRM1 (0.40) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL10159084 0.86 MAPT (0.66) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL18656937 0.83 KMT2A (0.70) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL18656864 0.78 MAPT (0.40) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL18656873 0.77 KMT2A (0.44) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL13067890 0.75 MAPT (0.47) MAPTKMT2AMEN1HSD17B10GAA
SCHEMBL10159296 0.75 MAPT (0.33) MAPTKMT2AMEN1HSD17B10USP2
SCHEMBL10159133 0.75 MAPT (0.33) MAPTKMT2AMEN1HSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3144299-A1 PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Cambria Pharmaceuticals, Inc. (US) 2017-03-22 — — EP disclosed
Send feedback